TAKEDA PHARMACEUTICAL CO Ltd. (NASDAQOTH:TKPHF)

CAPS Rating: No stars

Recs

1
Player Avatar mrevrgreen (87.89) Submitted: 8/4/2007 4:18:52 PM : Outperform Start Price: $65.35 TKPHF Score: -68.29

Takeda has a good pharmaceutical pipeline. It makes Actos a TZD for treatment of diabetes. It's major competitor (avandia by GSK) to the TZD market just had quite an unfoavorable study. The current recommendation is not to start anyone new on their competitors drug (Avandia).

I expect at least a 10% bump in new prescriptions.

Featured Broker Partners


Advertisement